62
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis

, , , , , , , , & show all
Pages 945-953 | Published online: 16 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yankui Liu, Longhai Li, Yu Tian, Xiao Zhu, Aijuan Sun, Yulong Sun, Yan Qiao, Xiaowei Qi & Tao Wang. (2021) Analysis of KRAS mutations in circulating tumor DNA and colorectal cancer tissue. Biotechnic & Histochemistry 96:5, pages 376-383.
Read now
Chengbao Feng, Jingjing Wang, Xue Yang, Xuefang Zang, Haikun Zhou, Erying Zhang, Haifei Li, Bo Liu, Shumin Chen, Ying Wang, Peng Wang, Lixue Gao & Jinyan Liu. (2020) Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells. Cancer Management and Research 12, pages 10067-10075.
Read now

Articles from other publishers (23)

Vincenza Caputo, Fortunato Ciardiello, Carminia Maria Della Corte, Giulia Martini, Teresa Troiani & Stefania Napolitano. (2023) Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer. Exploration of Targeted Anti-tumor Therapy, pages 102-138.
Crossref
Verena Haselmann, Maren Hedtke & Michael Neumaier. (2022) Liquid profiling for cancer patient stratification in precision medicine – current status and challenges for successful implementation in standard care. Journal of Laboratory Medicine 46:4, pages 225-236.
Crossref
Verena Haselmann, Maren Hedtke & Michael Neumaier. (2022) Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care. Diagnostics 12:3, pages 748.
Crossref
Seyed Mohammad Kazem Aghamir, Rahil Mashhadi, Zeinab Ahadi, Mahdi Khoshchehreh & Diana Taheri. 2022. Liquid Biopsy in Urogenital Cancers and its Clinical Utility. Liquid Biopsy in Urogenital Cancers and its Clinical Utility 101 127 .
Justina Žvirblytė & Linas Mažutis. 2022. Microfluidics and Biosensors in Cancer Research. Microfluidics and Biosensors in Cancer Research 499 524 .
Mahendra Naidoo, Oliver Piercey & Jeanne Tie. (2021) Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?. Current Oncology Reports 23:12.
Crossref
M. I. Sluzhev, V. V. Semiglazov, T. Yu. Semiglazova, E. V. Tkachenko, S. A. Protsenko, D. Kh. Latipova, S. V. Kondratev, N. A. Brish, Yu. V. Alekseeva & A. M. Belyaev. (2021) THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE. Siberian journal of oncology 20:5, pages 149-161.
Crossref
Adrian Albulescu, Adriana Plesa, Alina Fudulu, Iulia Iancu, Gabriela Anton & Anca Botezatu. (2021) Epigenetic approaches for cervical neoplasia screening (Review). Experimental and Therapeutic Medicine 22:6.
Crossref
Benjamín Durán-Vinet, Karla Araya-Castro, Juan Calderón, Luis Vergara, Helga Weber, Javier Retamales, Paulina Araya-Castro & Pamela Leal-Rojas. (2021) CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review. Cancers 13:18, pages 4640.
Crossref
Michail Ignatiadis, George W. Sledge & Stefanie S. Jeffrey. (2021) Liquid biopsy enters the clinic — implementation issues and future challenges. Nature Reviews Clinical Oncology 18:5, pages 297-312.
Crossref
Rui Wang, Aiguang Zhao, Nida Cao, Zhaoyan Li, Guangtao Zhang & Feng Liu. (2020) The value of circulation tumor DNA in predicting postoperative recurrence of colorectal cancer: a meta-analysis. International Journal of Colorectal Disease 35:8, pages 1463-1475.
Crossref
Pouya Amrollahi, Meryl Rodrigues, Christopher J. Lyon, Ajay Goel, Haiyong Han & Tony Y. Hu. (2019) Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular Vesicles. Frontiers in Genetics 10.
Crossref
James P. Solomon & Jaclyn F. Hechtman. (2019) Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic Platforms . Cancer Research 79:13, pages 3163-3168.
Crossref
Alessia Cimadamore, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli & Rodolfo Montironi. (2019) Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy. Cancers 11:2, pages 196.
Crossref
Daphne Day, Sophia Frentzas, Cameron A. Naidu, Eva Segelov & Maja Green. 2019. Advances in the Molecular Understanding of Colorectal Cancer. Advances in the Molecular Understanding of Colorectal Cancer.
S. Kruger, V. Heinemann, C. Ross, F. Diehl, D. Nagel, S. Ormanns, S. Liebmann, I. Prinz-Bravin, C.B. Westphalen, M. Haas, A. Jung, T. Kirchner, M. von Bergwelt-Baildon, S. Boeck & S. Holdenrieder. (2018) Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer. Annals of Oncology 29:12, pages 2348-2355.
Crossref
Jason D. Merker, Geoffrey R. Oxnard, Carolyn Compton, Maximilian Diehn, Patricia Hurley, Alexander J. Lazar, Neal Lindeman, Christina M. Lockwood, Alex J. Rai, Richard L. Schilsky, Apostolia M. Tsimberidou, Patricia Vasalos, Brooke L. Billman, Thomas K. Oliver, Suanna S. Bruinooge, Daniel F. Hayes & Nicholas C. Turner. (2018) Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Archives of Pathology & Laboratory Medicine 142:10, pages 1242-1253.
Crossref
Ying-Chi Yang, Dong Wang, Lan Jin, Hong-Wei Yao, Jing-Hui Zhang, Jin Wang, Xiao-Mu Zhao, Chun-Ying Shen, Wei Chen, Xue-Liang Wang, Rong Shi, Si-Yi ChenZhong-Tao Zhang. (2018) Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients. Bioscience Reports 38:4.
Crossref
Jason D. MerkerGeoffrey R. OxnardCarolyn ComptonMaximilian DiehnPatricia HurleyAlexander J. LazarNeal LindemanChristina M. LockwoodAlex J. RaiRichard L. SchilskyApostolia M. TsimberidouPatricia VasalosBrooke L. BillmanThomas K. OliverSuanna S. BruinoogeDaniel F. HayesNicholas C. Turner. (2018) Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Journal of Clinical Oncology 36:16, pages 1631-1641.
Crossref
Annette R. Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M. B. Jylling, Jeanette D. Jensen, Anne‐Vibeke Lænkholm, Ann S. Knoop & Henrik J. Ditzel. (2018) Correlation between circulating cell‐free PIK 3 CA tumor DNA levels and treatment response in patients with PIK 3 CA ‐mutated metastatic breast cancer . Molecular Oncology 12:6, pages 925-935.
Crossref
Myrto Kastrisiou, George Zarkavelis, Eleftherios Kampletsas, Eleni Panopoulou, Anna Goussia, George Nasioulas, Eirini Papadopoulou, Christina Tsaousi & George Pentheroudakis. (2018) Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literature. ESMO Open 3:4, pages e000329.
Crossref
Phillip Fleshner, Glenn D. Braunstein, Gayane Ovsepyan, Theresa R. Tonozzi & Anja Kammesheidt. (2018) Tumor-associated DNA mutation detection in individuals undergoing colonoscopy. Cancer Medicine 7:1, pages 167-174.
Crossref
Alexios Matikas, Alexandra Voutsina, Eleni Lagoudaki, Dora Hatzidaki, Maria Trypaki, Giannis Stoupis, Maria Tzardi, Dimitrios Mavroudis & Vasilios Georgoulias. (2017) Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer. Translational Oncology 10:4, pages 693-698.
Crossref